Anti-Reflux Device Market Size, Share, By Type of Device (Laparoscopic Linx System, Endoscopic Stretta Procedure, Hiatal Hernia Repair Surgery, Prevention of Esophageal Barrett's Disease, and Other Anti-Reflux Devices), By Application (Treatment of Gastroesophageal Reflux Disease, and Treatment of Other Acid Reflux-Related Conditions), By End User (Hospitals, Ambulatory Surgery Centers, and Others), and By Region - Trends, Analysis and Forecast till 2034

Report Code: PMI560024 | Publish Date: September 2024 | No. of Pages: 175

Anti Reflux Device Market Companies

  • Medtronic
  • Johnson & Johnson
  • EndoGastric Solutions, Inc.
  • Torax Medical, Inc. (Acquired by Johnson & Johnson)
  • Boston Scientific Corporation
  • Medigus Ltd.
  • InSightec Ltd.
  • Olympus Corporation
  • Mederi Therapeutics, Inc.
  • Abbott Laboratories
  • EndoStim, Inc.
  • Stryker Corporation
  • Allergan plc (Acquired by AbbVie)
  • Ethicon, Inc. (A subsidiary of Johnson & Johnson)
  • B. Braun Melsungen AG

Recent News:

  • Medtronic introduced a next-generation laparoscopic Linx Reflux Management System in August 2024, enhancing the magnetic augmentation device's comfort and efficacy. This announcement comes after promising clinical trial outcomes demonstrating a notable decrease in GERD patients' symptoms.
  • Boston Scientific announced in June 2024 that it would expand its product line by acquiring Mederi Therapeutics, Inc., a company best known for the Stretta procedure. This acquisition aims to give patients with GERD more non-surgical choices from Boston Scientific.
  • Olympus Corporation debuted its most recent endoscopic treatment system for GERD in April 2024. It features improved imaging technologies that aid in accurate device placement throughout treatments.